Esperion Therapeutics
ESPREsperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Esperion Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 6/17/2025 | Sell | Halladay, Benjamin | Chief Financial Officer | $1.2 | $8,328 |
| 6/17/2025 | Sell | Koenig, Sheldon L. | President and CEO | $1.1 | $33,796 |
| 6/17/2025 | Sell | Looker, Benjamin | General Counsel | $1.2 | $7,398 |
| 4/17/2025 | Sell | Halladay, Benjamin | Chief Financial Officer | $1.0 | $8 |
| 4/17/2025 | Sell | Warren, Eric | Chief Commercial Officer | $1.0 | $106 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)